The amount of bone formed under each condition was assessed by solubilising the mineral content in hydrochloric acid overnight and then measuring the change in colour induced by Calcium exposed to a commercial reagent. The amount of calcium detected was then determined using a standard curve. This experiment was repeated in cells from 3 patients.
There was a statistically significant impairment in osteogenesis at a concentration of tobramycin of 400 microg/ml and above.
The longevity of cemented femoral components has been shown to be related to the cement used. The reason for this difference between the available commercial preparations is unclear. One mode of failure of the stem is thought to be cracking within the cement mantle. This may be secondary to residual stress resulting from shrinkage of the cement on curing. It was hypothesised that there was a difference in shrinkage on curing between the different polymethylmethacrylate cements used commonly in hip arthroplasty. Under standardised conditions, a fixed volume of Palacos-R, Palacos-LV, Simplex, CMW1 Radio-opaque, CMW2 and CMW Endurance was mixed under vacuum and allowed to cure in a measuring cylinder of fixed volume. The cylinder was then split open 24 hours later and the block of cement removed. The final volume of cement was then determined by measuring the volume it occupied in a container filled with water using Archimedes principle. Our results indicate that, under standardised conditions, the degree of shrinkage for each commercial preparation was Palacos-R 6.9%, CMW1 5.2%, CMW2 5.4%, CMW Endurance 5.3%, Simplex 5.8% and Palacos-LV 7.2%. There is a difference in the amount of shrinkage on curing between the different types of bone cements in use commercially and this may account for their differences in long term outcome.
Implantation of allograft bone continues to be an integral part of revision hip surgery. One major concern with its use is the risk of transmission of infective agents. There are a number of methods of processing bone in order to reduce that risk. One part of that processing can be carried out immediately prior to implantation using pulsed irrigation. We report the incidence of deep bacterial infection in a series of 138 patients undergoing 144 revision hip arthroplasty procedures who had undergone allograft bone implantation. The allograft bone used was fresh-frozen non-irradiated. Allograft femoral heads were milled following removal of any residual soft tissue and sclerotic subchondral bone. The bone chips were then placed in a standard metal sieve and irrigated with Normal Saline (pre-warmed to 60 degrees Centigrade) delivered as pulsed lavage at 7 bar pressure. No antibiotics were used in the irrigation solution. The bone chips were washed until all visible blood and marrow products had been removed. The deep infection rate at a minimum one year follow-up was 0.6%. This method of secondary processing appears to be consistent with a very low risk of allograft related bacterial infection.